Regulatory/Legal

Ensure compliance with external submission standards. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in pharmaceutical regulatory affairs to exchange ideas on best practice and share case studies on innovation within the area.
 


Mapping the Data Universe: Big Data Presents Big Challenges for the Pharmaceutical Sector - Martin Bonney

Adopting a continual, pro-active approach to information governance is essential if pharmaceutical companies are to meet the challenges presented by big data. Full Article »


Events related to this topic:

Top 10 Trends that will Shape Pharma

Contributor: Pharma IQ
Posted: 8/22/2013


Top 10 Trends that will Shape Pharma - Pharma IQ

The global pharmaceutical industry has undergone some rapid changes in recent years, but what are the Top 10 Trends that will Shape Pharma. Pharma IQ investigate in this 3 minute video. Full Video »


Events related to this topic:

Ben Goldacre Makes the Case for Greater Transparency in Clinical Trials - Gerald Clarke

"Clinical trial information is being routinely and legally witheld and this needs to end." This is the assertion of Dr. Ben Goldacre; a doctor, science writer, campaigner on scientific issues including clinical trial transparency and author of the book Bad Pharma. Pharma IQ discussed the issue of clinical trial transparency with Dr. Goldacre, with a focus on how it will affect industry and why pharma companies have taken differing strategies in response to the campaign. Full Podcast »


Events related to this topic:

Ensuring Effective Translations - Introduction

Contributor: Andrew Love
Posted: 3/6/2015


Ensuring Effective Translations - Introduction - Andrew Love

As globalisation increases and companies reach customers in many more markets around the world, the need for accurate and comprehensive translations increases. Full Column »


Events related to this topic:

IDMP Compliance — Get Ready

IDMP regulations (Identification of Medicinal Products) are currently being finalised by both the European Medicines Agency (EMA) and the Food and Drug Administration (FDA). These regulations will be based on standards created by the International Organization for Standardisation (ISO). In Europe, these regulations will go into effect in July, 2016. Read on to find out more about the position of the FDA, what is included in the standards, and what the implementation of IDMP will require from all divisions and branches of pharmaceutical companies. Full Whitepaper »


Events related to this topic:



Advertise With Us

Join the Pharmas IQ Community